share_log

Today's biggest pre-market stock movers: ALNA, NRBO, OGEN and more

Benzinga Real-time News ·  Jan 4, 2022 07:49  · Movers

Gainers

  • $Allena Pharmaceuticals(ALNA.US)$ rose 40.13% to $0.906 in pre-market trading as the company issued a clinical and corporate update.

  • $NeuroBo Pharmaceuticals(NRBO.US)$ rose 28.55% to $1.72 in pre-market trading after gaining around 10% on Monday.

  • $Oragenics(OGEN.US)$ rose 25.85% to $0.595 in pre-market trading. The company reported in Form 4 filing that Director Robert Koski bought 1 million shares at an average price of $0.47 per share.

  • $Immix Biopharma(IMMX.US)$ rose 23.53% to $7.14 in pre-market trading. Immix Biopharma shares jumped 62% on Monday after the company announced the FDA granted Rare Pediatric Disease designation for IMX-110 for the treatment of a life-threatening form of pediatric cancer in children, rhabdomyosarcoma.

  • $TherapeuticsMD(TXMD.US)$ rose 12.3% to $0.442 in pre-market trading. TherapeuticsMD, last month, said that the FDA could not approve revisions to certain manufacturing testing limits for Annovera through the supplemental marketing application previously submitted by the Company.

  • $Liquidia(LQDA.US)$ rose 9.90% to $5.649 in pre-market trading. Liquidia named Dr. Roger Jeffs as Chief Executive Officer (CEO) effective January 3, 2022.

  • $Borr Drilling(BORR.US)$ rose 9.3% to $2.36 in pre-market trading. Borr Drilling recently reported an agreement to defer $1.4 billion of debt maturities and yard instalments to 2025.

  • $AEterna Zentaris(AEZS.US)$ rose 9.2% to $0.43 in pre-market trading. Aeterna Zentaris recently named Giuliano La Fratta as Chief Financial Officer.

  • $TPI Composites(TPIC.US)$ rose 6.6% to $16.05 in pre-market trading.

Losers

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment